Deferential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system

Chih Shan Chen, Bernadette Lyons-Giordano, Gerald Sylvan Lazarus, Pamela J. Jensen

Research output: Contribution to journalArticle

Abstract

Uatag immunohistochemistry and in situ hybridization, we have characterized the expression and localization of components of the plasminogen activator proteolytic cascade in an organotypic coculture system which consists of a "dermal" portion (human dermal fibroblasts throughout a collagen matrix) and a stratified, well-differentiated epidermal portion. Specifically, the following components were examined: the enzymes urokinasetype plasminogen activator and tissue-type plasminogen activator and their type 1 and type 2 inhibitors. Urokinase plasminogen activator mRNA and antigen were found predominantly in the least differentiated, basal keratinocytes; in some fields there was also faint deposition of antigen beneath the basal cells. The distribution of plasminogen activator inhibitor type 1 was similar to that of urokinase, except that inhibitor type 1 antigen deposition beneath the basal cells appeared more intense and uniform. In contrast to the results with urokinase plasminogen activator and inhibitor type 1, tissue plasminogen activator mRNA and antigen were localized focally in the suprabasal, i.e. more differentiated, keratinocytes. Plasminogen activator inhibitor type 2 mRNA and antigen were detected in most epidermal layers, but were more intense suprabasally and often spared the basal layer. These studies demonstrate that the same type of cell, i.e. the keratinocyte, can express different components of the plasminogen activator cascade depending on its state of differentiation. The change in expression of plasminogen activator cascade components with keratinocyte differentiation suggests distinct epidermal functions for these components, related to cell-matrix interaction and epidermal differentiation.

Original languageEnglish (US)
Pages (from-to)45-53
Number of pages9
JournalJournal of Cell Science
Volume106
Issue number1
StatePublished - 1993
Externally publishedYes

Fingerprint

Plasminogen Inactivators
Plasminogen Activators
Coculture Techniques
Keratinocytes
Antigens
Skin
Urokinase-Type Plasminogen Activator
Tissue Plasminogen Activator
Messenger RNA
Plasminogen Activator Inhibitor 2
Plasminogen Activator Inhibitor 1
Cell Communication
In Situ Hybridization
Collagen
Fibroblasts
Immunohistochemistry
Enzymes

Keywords

  • Differentiation
  • Keratinocytes
  • Plasminogen activator inhibitors
  • Plasminogen activators
  • Skin equivalent

ASJC Scopus subject areas

  • Cell Biology

Cite this

Deferential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. / Chen, Chih Shan; Lyons-Giordano, Bernadette; Lazarus, Gerald Sylvan; Jensen, Pamela J.

In: Journal of Cell Science, Vol. 106, No. 1, 1993, p. 45-53.

Research output: Contribution to journalArticle

Chen, Chih Shan ; Lyons-Giordano, Bernadette ; Lazarus, Gerald Sylvan ; Jensen, Pamela J. / Deferential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. In: Journal of Cell Science. 1993 ; Vol. 106, No. 1. pp. 45-53.
@article{233e9a405460454f9c413f82223232ef,
title = "Deferential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system",
abstract = "Uatag immunohistochemistry and in situ hybridization, we have characterized the expression and localization of components of the plasminogen activator proteolytic cascade in an organotypic coculture system which consists of a {"}dermal{"} portion (human dermal fibroblasts throughout a collagen matrix) and a stratified, well-differentiated epidermal portion. Specifically, the following components were examined: the enzymes urokinasetype plasminogen activator and tissue-type plasminogen activator and their type 1 and type 2 inhibitors. Urokinase plasminogen activator mRNA and antigen were found predominantly in the least differentiated, basal keratinocytes; in some fields there was also faint deposition of antigen beneath the basal cells. The distribution of plasminogen activator inhibitor type 1 was similar to that of urokinase, except that inhibitor type 1 antigen deposition beneath the basal cells appeared more intense and uniform. In contrast to the results with urokinase plasminogen activator and inhibitor type 1, tissue plasminogen activator mRNA and antigen were localized focally in the suprabasal, i.e. more differentiated, keratinocytes. Plasminogen activator inhibitor type 2 mRNA and antigen were detected in most epidermal layers, but were more intense suprabasally and often spared the basal layer. These studies demonstrate that the same type of cell, i.e. the keratinocyte, can express different components of the plasminogen activator cascade depending on its state of differentiation. The change in expression of plasminogen activator cascade components with keratinocyte differentiation suggests distinct epidermal functions for these components, related to cell-matrix interaction and epidermal differentiation.",
keywords = "Differentiation, Keratinocytes, Plasminogen activator inhibitors, Plasminogen activators, Skin equivalent",
author = "Chen, {Chih Shan} and Bernadette Lyons-Giordano and Lazarus, {Gerald Sylvan} and Jensen, {Pamela J.}",
year = "1993",
language = "English (US)",
volume = "106",
pages = "45--53",
journal = "Journal of Cell Science",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "1",

}

TY - JOUR

T1 - Deferential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system

AU - Chen, Chih Shan

AU - Lyons-Giordano, Bernadette

AU - Lazarus, Gerald Sylvan

AU - Jensen, Pamela J.

PY - 1993

Y1 - 1993

N2 - Uatag immunohistochemistry and in situ hybridization, we have characterized the expression and localization of components of the plasminogen activator proteolytic cascade in an organotypic coculture system which consists of a "dermal" portion (human dermal fibroblasts throughout a collagen matrix) and a stratified, well-differentiated epidermal portion. Specifically, the following components were examined: the enzymes urokinasetype plasminogen activator and tissue-type plasminogen activator and their type 1 and type 2 inhibitors. Urokinase plasminogen activator mRNA and antigen were found predominantly in the least differentiated, basal keratinocytes; in some fields there was also faint deposition of antigen beneath the basal cells. The distribution of plasminogen activator inhibitor type 1 was similar to that of urokinase, except that inhibitor type 1 antigen deposition beneath the basal cells appeared more intense and uniform. In contrast to the results with urokinase plasminogen activator and inhibitor type 1, tissue plasminogen activator mRNA and antigen were localized focally in the suprabasal, i.e. more differentiated, keratinocytes. Plasminogen activator inhibitor type 2 mRNA and antigen were detected in most epidermal layers, but were more intense suprabasally and often spared the basal layer. These studies demonstrate that the same type of cell, i.e. the keratinocyte, can express different components of the plasminogen activator cascade depending on its state of differentiation. The change in expression of plasminogen activator cascade components with keratinocyte differentiation suggests distinct epidermal functions for these components, related to cell-matrix interaction and epidermal differentiation.

AB - Uatag immunohistochemistry and in situ hybridization, we have characterized the expression and localization of components of the plasminogen activator proteolytic cascade in an organotypic coculture system which consists of a "dermal" portion (human dermal fibroblasts throughout a collagen matrix) and a stratified, well-differentiated epidermal portion. Specifically, the following components were examined: the enzymes urokinasetype plasminogen activator and tissue-type plasminogen activator and their type 1 and type 2 inhibitors. Urokinase plasminogen activator mRNA and antigen were found predominantly in the least differentiated, basal keratinocytes; in some fields there was also faint deposition of antigen beneath the basal cells. The distribution of plasminogen activator inhibitor type 1 was similar to that of urokinase, except that inhibitor type 1 antigen deposition beneath the basal cells appeared more intense and uniform. In contrast to the results with urokinase plasminogen activator and inhibitor type 1, tissue plasminogen activator mRNA and antigen were localized focally in the suprabasal, i.e. more differentiated, keratinocytes. Plasminogen activator inhibitor type 2 mRNA and antigen were detected in most epidermal layers, but were more intense suprabasally and often spared the basal layer. These studies demonstrate that the same type of cell, i.e. the keratinocyte, can express different components of the plasminogen activator cascade depending on its state of differentiation. The change in expression of plasminogen activator cascade components with keratinocyte differentiation suggests distinct epidermal functions for these components, related to cell-matrix interaction and epidermal differentiation.

KW - Differentiation

KW - Keratinocytes

KW - Plasminogen activator inhibitors

KW - Plasminogen activators

KW - Skin equivalent

UR - http://www.scopus.com/inward/record.url?scp=0027443815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027443815&partnerID=8YFLogxK

M3 - Article

C2 - 8270642

AN - SCOPUS:0027443815

VL - 106

SP - 45

EP - 53

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - 1

ER -